Ensign Group (ENSG) Beats Q2 2026 Estimates, Raises Full-Year EPS Guidance to $7.75-$7.85
Alpha Stocks Insight Staff
Independent stock news and analysis covering NASDAQ and NYSE markets.
Ensign Group lifted full-year EPS guidance to $7.75-$7.85 after Q2 GAAP EPS of $1.68 and revenue of $1.44B, up 17.3% year over year.
The Ensign Group (NASDAQ: ENSG) reported second-quarter 2026 GAAP diluted EPS of $1.68, up 16.7% from $1.44 in the prior-year quarter, alongside consolidated revenue of $1.44 billion, a 17.3% year-over-year increase. The company simultaneously raised its full-year 2026 EPS and revenue guidance, citing the quarter's financial performance and occupancy trends. Shares rose 2.94% on Monday, July 27, while the S&P 500 gained 0.02%.
Q2 2026 Results
- Revenue: $1.44 billion, up 17.3% year over year from approximately $1.23 billion in Q2 2025.
- GAAP net income: $99.7 million, up 18.2% from $84.3 million in the prior-year quarter; adjusted net income of $114.3 million, up 22.5% from $93.3 million.
- GAAP diluted EPS: $1.68, up 16.7% year over year; adjusted diluted EPS of $1.92, up 20.8% from $1.59.
- Same Facility occupancy: 84.1% for the quarter, up 2.7% versus the prior-year quarter; Transitioning Facility occupancy of 84.7%, up 2.3%.
- Standard Bearer segment revenue: $44.1 million, up 40.2% year over year; FFO of $24.7 million, up 34.6%.
What Drove the Results
Adjusted EPS of $1.92 exceeded GAAP EPS of $1.68 by $0.24, with the gap reflecting adjustments including acquisition-related costs and share-based compensation that are excluded from the non-GAAP figure. On the top line, skilled mix revenue for Same Facilities rose 10.1% year over year and 14.0% for Transitioning Facilities, while Medicare revenue grew 9.8% and 9.6% for those respective groups. Managed care revenue for Same Facilities increased 6.1% and for Transitioning Facilities 16.2%, with managed care days up 1.9% and 7.6% respectively.
During the quarter, Ensign added 20 new operations, all of which included real estate assets. Chief Investment Officer Chad Keetch noted that since 2024, the company has closed and transitioned 102 new operations across multiple markets. Liquidity at quarter-end included approximately $262.3 million in cash and $591.6 million of available capacity under the company's line of credit, per CFO Suzanne Snapper.
Guidance Raised
Ensign raised its full-year 2026 EPS guidance to a range of $7.75 to $7.85 per diluted share, up from the previously increased range of $7.48 to $7.62. The midpoint of the new range represents an 18.7% increase over 2025 and 41.8% over 2024, according to CEO Barry Port. Full-year revenue guidance was raised to $5.87 billion to $5.92 billion, from the prior range of $5.81 billion to $5.86 billion. The guidance assumes diluted weighted average shares outstanding of approximately 59.5 million and a 25.0% tax rate, and accounts for acquisitions expected to close through Q3 2026.
Wall Street View
Analyst sentiment on Ensign heading into the report leaned constructive, with the most recent consensus reflecting nine Buy-equivalent ratings and two Hold ratings. No specific price target changes were available in the source data as of publication.
Investor Takeaway
The combination of above-consensus EPS performance and an upward guidance revision suggests that Ensign's operating model, centered on local leadership accountability and disciplined acquisition integration, continues to convert occupancy gains into margin expansion. The raised full-year EPS midpoint of $7.80 implies further acceleration through the second half of 2026, with management explicitly factoring near-term acquisition closings into that outlook. Investors should note that the guidance explicitly excludes share-based compensation and acquisition-related costs, so the GAAP outcome will depend on the pace and size of deals completed in Q3.
Editorial oversight by Teodora Hristova, Founder & Editor
Related Coverage
- Baker Hughes (NASDAQ:BKR) Q2 2026: Adjusted EPS Beats by 25%, IET Orders Double YoY to $7.1BBKR · Monday, July 27, 2026
- Quest Diagnostics (NYSE: DGX) Q2 2026: Revenue Jumps 10.2%, Adjusted EPS Beats by 9.5%DGX · Friday, July 24, 2026
- American Express (NYSE: AXP) Q2 2026: EPS of $4.53 Beats Estimates, Revenue Guidance Raised to 10%AXP · Friday, July 24, 2026
- Chubb (NYSE: CB) Q2 2026: Core Operating EPS of $7.26 Beats $6.95 Estimate, Up 18.2% YoYCB · Thursday, July 23, 2026
Important Legal Disclaimer
This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.
Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.
